We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors). Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell...
On track to report initial clinical and translational data from lead CAR T-cell and TIL product candidates in 2024Received Orphan Drug Designation for LYL845 for the treatment of melanomaExpect to...
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell...
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.14 | -6.27802690583 | 2.23 | 2.55 | 2.11 | 660320 | 2.33121193 | CS |
4 | -0.18 | -7.9295154185 | 2.27 | 3.145 | 2.015 | 955950 | 2.43148161 | CS |
12 | 0.31 | 17.4157303371 | 1.78 | 3.2556 | 1.69 | 916242 | 2.30086949 | CS |
26 | 0.48 | 29.8136645963 | 1.61 | 3.2556 | 1.52 | 1129408 | 2.10277925 | CS |
52 | 0.08 | 3.98009950249 | 2.01 | 3.97 | 1.32 | 1020708 | 2.31230644 | CS |
156 | -16.66 | -88.8533333333 | 18.75 | 19.84 | 1.32 | 940239 | 4.80700351 | CS |
260 | -16.66 | -88.8533333333 | 18.75 | 19.84 | 1.32 | 940239 | 4.80700351 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions